DR. MARK L. GINKEL, MD

SANTA MARIA, CA

Research Active
Internal Medicine - Cardiovascular Disease NPI registered 21+ years 10 publications 1994 – 2022 NPI: 1649272766
Databases, FactualSignal TransductionUser-Computer InterfaceComputer SimulationProteomeModels, BiologicalSoftwareDocumentationSystems BiologyData AnalysisMetabolismComputer GraphicsProgramming LanguagesSoftware DesignInformation Storage and Retrieval

Practice Location

220 S PALISADE DR
SANTA MARIA, CA 93454-8902

Phone: (805) 354-0112

What does MARK GINKEL research?

Dr. Ginkel studies how to make the analysis of scientific data easier and more efficient, especially in the context of drug discovery and biological modeling. He works on conditions that involve the interactions of drugs with ion channels and signaling networks, which are essential for understanding how to develop new therapies. By creating advanced software tools, he enables researchers to analyze complex biochemical networks and enhance the drug development process, ensuring that therapies are effective and delivered more quickly to patients.

Key findings

  • Dr. Ginkel's 2022 study led to a new software tool that processes data from automated electrophysiology tests, significantly speeding up drug development.
  • In 2017, he developed a software solution for surface plasmon resonance (SPR) data analysis, reducing time spent on quality checks by allowing immediate results.
  • His 2008 research introduced a method for breaking down biochemical signaling networks into manageable parts, improving the clarity of functional studies.
  • The FluxAnalyzer tool created in 2003 can analyze metabolic networks with more than 500,000 pathways, making it easier to understand complex biochemical reactions.
  • His 2009 PROMOT tool improved model validation in systems biology, leading to more accurate representations of biological processes.

Frequently asked questions

Does Dr. Ginkel study drug development?
Yes, Dr. Ginkel focuses on improving the data analysis processes in drug development, particularly how drugs interact with biological systems.
What tools has Dr. Ginkel created for researchers?
He has developed multiple software tools, including those for analyzing data from electrophysiology tests and surface plasmon resonance, which improve the efficiency of drug research.
Is Dr. Ginkel's work relevant to understanding diseases?
Absolutely. His research helps scientists analyze complex biological processes related to diseases, ultimately leading to better treatments.
What biological systems does Dr. Ginkel model?
Dr. Ginkel models various biochemical networks, including metabolic pathways and signaling networks, to enhance understanding of cellular functions.
Can Dr. Ginkel's research assist in personalized medicine?
Yes, by streamlining the analysis of drug interactions and biological models, his tools can help tailor treatments to individual patient needs.

Publications in plain English

An efficient and scalable data analysis solution for automated electrophysiology platforms.

2022

SLAS discovery : advancing life sciences R & D

Li T, Ginkel M, Yee AX, Foster L, Chen J +2 more

Plain English
This study focused on improving the way scientists analyze data from automated tests that measure how drugs affect ion channels, which are important for treating various diseases. The researchers created a new software tool that can quickly and systematically process large amounts of data, allowing for a better understanding of how drugs work on ion channels. This is significant because it can speed up drug development and provide deeper insights into drug effects, ultimately leading to more effective treatments. Who this helps: This helps patients and drug developers by improving the drug discovery process.

PubMed

Unified Software Solution for Efficient SPR Data Analysis in Drug Research.

2017

SLAS discovery : advancing life sciences R & D

Dahl G, Steigele S, Hillertz P, Tigerström A, Egnéus A +12 more

Plain English
This research focused on improving the way scientists analyze data from a method called surface plasmon resonance (SPR), which is used in drug discovery to study how molecules interact. The study introduced a new software tool that processes and analyzes SPR data quickly, allowing results to be available immediately and improving quality checks. Using this software can save time and streamline the reporting process in drug research, making the overall workflow much more efficient. Who this helps: This benefits researchers and pharmaceutical companies involved in drug development.

PubMed

SBML Level 3 package: Hierarchical Model Composition, Version 1 Release 3.

2015

Journal of integrative bioinformatics

Smith LP, Hucka M, Hoops S, Finney A, Ginkel M +3 more

Plain English
This study introduces a new feature for a modeling system called SBML that allows researchers to organize complex models into simpler, nested parts. The new tool enables scientists to add, change, or remove parts of a model more easily, and it even provides a way to create connections between these parts. This is important because it makes modeling more efficient and flexible, helping researchers work better with complex biological systems. Who this helps: This helps researchers and scientists who build and use biological models.

PubMed

PROMOT: modular modeling for systems biology.

2009

Bioinformatics (Oxford, England)

Mirschel S, Steinmetz K, Rempel M, Ginkel M, Gilles ED

Plain English
This research paper discusses a tool called PROMOT, which helps scientists create and edit biological models more easily. The latest version has improved features for developing complex models and visually exploring data, making it simpler to validate findings. This matters because better models lead to clearer understanding in systems biology, which impacts research and development in health and disease. Who this helps: Researchers and scientists in the field of biology.

PubMed

Automatic decomposition of kinetic models of signaling networks minimizing the retroactivity among modules.

2008

Bioinformatics (Oxford, England)

Saez-Rodriguez J, Gayer S, Ginkel M, Gilles ED

Plain English
This study focused on improving the way scientists analyze biochemical signaling networks by breaking them down into smaller, easier-to-understand parts called modules. Researchers introduced a new method that reduces unwanted interactions (called retroactivity) between these modules, making it simpler to study complex networks. For example, when applied to models of EGF signaling, the method successfully identified meaningful modules, helping to streamline the analysis of large biochemical systems. Who this helps: This benefits researchers and scientists working on understanding complex signaling pathways and developing targeted therapies.

PubMed

Visual setup of logical models of signaling and regulatory networks with ProMoT.

2006

BMC bioinformatics

Saez-Rodriguez J, Mirschel S, Hemenway R, Klamt S, Gilles ED +1 more

Plain English
This study developed a new software tool called ProMoT that helps scientists create and analyze complex models of biochemical signaling and regulatory networks in a simple and visual way. The tool allows for easy setup of large logical models, which are described using a straightforward method, making it versatile for different research needs. This is important because it enables better understanding and exploration of how biological processes work at a cellular level. Who this helps: This helps researchers and scientists studying cellular biology and biochemistry.

PubMed

FluxAnalyzer: exploring structure, pathways, and flux distributions in metabolic networks on interactive flux maps.

2003

Bioinformatics (Oxford, England)

Klamt S, Stelling J, Ginkel M, Gilles ED

Plain English
The study developed a tool called FluxAnalyzer that helps scientists analyze metabolic networks, which are systems of biochemical reactions in cells. This tool allows users to create detailed visual maps of these networks and perform various analyses, which can handle complex networks involving over 500,000 pathways. This is important because it makes understanding how metabolic systems function much easier and more accessible, which can lead to better research in health and diseases. Who this helps: This helps researchers and scientists studying metabolism-related diseases.

PubMed

The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models.

2003

Bioinformatics (Oxford, England)

Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC +39 more

Plain English
This research focuses on the Systems Biology Markup Language (SBML), which is a free and open format used to represent complex biochemical network models. The study emphasizes SBML Level 1, which allows researchers to easily share and develop these models across different software platforms. This is important because it enables better collaboration and evaluation of scientific research related to areas like cell signaling and metabolism. Who this helps: This helps researchers and scientists working in molecular biotechnology and computational biology.

PubMed

Modular modeling of cellular systems with ProMoT/Diva.

2003

Bioinformatics (Oxford, England)

Ginkel M, Kremling A, Nutsch T, Rehner R, Gilles ED

Plain English
This research focused on creating software that helps scientists build and analyze complex models of cellular systems. They developed a framework called ProMoT, which allows for the easy construction of modular models, making it simpler to understand how cells work. This software is important because it helps researchers simulate and study intricate biochemical processes more effectively. Who this helps: This benefits researchers and scientists studying cellular behavior and biochemical networks.

PubMed

Magnesium therapy in new-onset atrial fibrillation.

1994

The American journal of cardiology

Brodsky MA, Orlov MV, Capparelli EV, Allen BJ, Iseri LT +2 more

PubMed

Frequent Co-Authors

Ernst Dieter Gilles Stephan Heyse Stephan Steigele Sebastian Mirschel Julio Saez-Rodriguez Steffen Klamt A Kremling E D Gilles Tianbo Li Ada X Yee

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.